Statins Cause Muscle Pain in Less Than 10% of Patients

August 30, 2022 by Dan McCue
Statins Cause Muscle Pain in Less Than 10% of Patients
This June 14, 2011, file photo, shows the pills of the drug Lipitor in Willingboro, N.J. (AP Photo/Matt Rourke, File)

BARCELONA, Spain — Statins have long been seen as an important intervention in preventing serious cardiovascular episodes, but many patients stop taking them over time because of side effects like digestive issues, sleep disruptions and muscle pain.

However, a study presented this week at the European Society of Cardiology Congress in Spain suggests that for more than 90% of patients on statins who experience muscle pain, the statins are not the cause.

In fact, according to the study which was published in The Lancet, while statin therapy has been found to produce a 7% relative increase in muscle pain or weakness, the researchers found no significant increase after that.

Their findings are consistent with other studies that have shown that less than 10% of people have muscle-related symptoms like muscle aches that seem to be associated with taking a statin.

“Our results confirm that, in the majority of cases, statin therapy is not likely to be the cause of muscle pain in a person taking statin therapy,” the study says. “This finding is particularly true if the treatment has been well tolerated for a year or more before developing symptoms.”

The study was conducted by researchers from Oxford Population Health and the Medical Research Council Population Health Research Unit at the University of Oxford in the United Kingdom.

Over the course of their research, the authors conducted a meta-analysis — a statistical analysis that combines the results of multiple scientific studies — of 19 randomized double-blind trials of statin regimens versus placebos. 

All trials had over 1,000 participants and at least two years of follow-up. 

They also looked at an additional four double-blind trials of more and less intense statin regimens.

The authors said in the trials they looked at, statin therapy caused approximately 11 additional muscle pain reports per 1,000 patients in the first year of use.

They said this finding suggests medical practitioners need to do a better job of managing patients’ pain so that they don’t forgo statins and suffer worse impacts to their long term health.

In addition, they said the profession — and drug manufacturers — need to take a closer look at the information about things like muscle pain that is available to patients in the package inserts they receive with their medication.

According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for men, women and people of most racial and ethnic groups in the United States. 

There is one cardiovascular disease death every 34 seconds in the country, the CDC says.

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue.

A+
a-
  • cardiovascular
  • muscle pain
  • pain management
  • Statins
  • treatment
  • In The News

    Health

    Voting

    Health

    EPA Designates Two Forever Chemicals as Hazardous Substances, Eligible for Superfund Cleanup

    WASHINGTON (AP) — The Environmental Protection Agency on Friday designated two forever chemicals that have been used in cookware, carpets and firefighting... Read More

    WASHINGTON (AP) — The Environmental Protection Agency on Friday designated two forever chemicals that have been used in cookware, carpets and firefighting foams as hazardous substances, an action intended to ensure quicker cleanup of the toxic compounds and require industries and others responsible for contamination to pay for... Read More

    April 18, 2024
    by Beth McCue
    Salmonella Outbreak Linked to Fresh Basil 

    ATLANTA — The Centers for Disease Control and Prevention on Thursday issued a food safety alert regarding Infinite Herbs organic... Read More

    ATLANTA — The Centers for Disease Control and Prevention on Thursday issued a food safety alert regarding Infinite Herbs organic basil. As of the alert, 12 Salmonella cases in seven states have been reported. There are no reported deaths. The basil was sold at Trader Joe’s... Read More

    April 17, 2024
    by Dan McCue
    Eli Lilly Obesity Drug Appears to Ease Sleep Apnea Symptoms in Trials

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its... Read More

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its obesity drug, Zepbound, can provide considerable relief to overweight people who have sleep apnea. Though the findings have yet to be published in a peer-reviewed medical... Read More

    Idaho's Ban on Youth Gender-Affirming Care Has Families Desperately Scrambling for Solutions

    Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when... Read More

    Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when she began to take medication to block the onset of puberty. The gender-affirming treatment helped the now-16-year-old find happiness again, her father said. A decision by the... Read More

    Weedkiller Manufacturer Seeks Lawmakers' Help to Squelch Claims It Failed to Warn About Cancer

    DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been... Read More

    DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been lobbying lawmakers in three states to pass bills providing it a legal shield from lawsuits that claim its popular weedkiller Roundup causes cancer. Nearly identical bills... Read More

    April 16, 2024
    by Dan McCue
    Agency Sets Rules Limiting Miners’ Exposure to Hazardous Silica Dust

    WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s... Read More

    WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s miners from health hazards associated with exposure to respirable crystalline silica, also known as silica dust.  Inhaling crystalline silica, a known carcinogen, can cause serious lung... Read More

    News From The Well
    scroll top